Evidence map›Paper›PMID 29444167›Full record

ArticlePloS one2018

Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada.

Sarah E Wilson, Hannah Chung, Kevin L Schwartz, Astrid Guttmann, Shelley L Deeks, Jeffrey C Kwong, Natasha S Crowcroft, Laura Wing, Karen Tu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Immunization status of children at kindergarten entry in Alberta, Canada.Canadian journal of public health = Revue canadienne de sante publique · 2023
    Article
  8. Article
  9. Observational
  10. Rotavirus vaccines: progress and new developments.Expert opinion on biological therapy · 2022
    Review
  11. Article
  12. Review
  13. The impact of publicly funded rotavirus immunization programs on Canadian children.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sarah E WilsonPublic Health Ontario, Toronto, Ontario, Canada.ORCID 0000-0002-8239-0094
Hannah ChungInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Kevin L SchwartzPublic Health Ontario, Toronto, Ontario, Canada.
Astrid GuttmannInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Shelley L DeeksPublic Health Ontario, Toronto, Ontario, Canada.
Jeffrey C KwongPublic Health Ontario, Toronto, Ontario, Canada.
Natasha S CrowcroftPublic Health Ontario, Toronto, Ontario, Canada.
Laura WingInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Karen TuInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
University of Toronto · CAInstitute for Clinical Evaluative Sciences · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn August 2011, Ontario, Canada introduced a rotavirus immunization program using Rotarix™ vaccine. No assessments of rotavirus vaccine coverage have been previously conducted in Ontario.

methodsWe assessed vaccine coverage (series initiation and completion) and factors associated with uptake using the Electronic Medical Record Administrative data Linked Database (EMRALD), a collection of family physician electronic medical records (EMR) linked to health administrative data. Series initiation (1 dose) and series completion (2 doses) before and after the program's introduction were calculated. To identify factors associated with series initiation and completion, adjusted odds ratios (aOR) and 95% confidence intervals (95%CI) were calculated using logistic regression.

resultsA total of 12,525 children were included. Series completion increased each year of the program (73%, 79% and 84%, respectively). Factors associated with series initiation included high continuity of care (aOR = 2.15; 95%CI, 1.61-2.87), maternal influenza vaccination (aOR = 1.55; 95%CI,1.24-1.93), maternal immmigration to Canada in the last five years (aOR = 1.47; 95% CI, 1.05-2.04), and having no siblings (aOR = 1.62; 95%CI,1.30-2.03). Relative to the first program year, infants were more likely to initiate the series in the second year (aOR = 1.71; 95% CI 1.39-2.10) and third year (aOR = 2.02; 95% CI 1.56-2.61) of the program. Infants receiving care from physicians with large practices were less likely to initiate the series (aOR 0.91; 95%CI, 0.88-0.94, per 100 patients rostered) and less likely to complete the series (aOR 0.94; 95%CI, 0.91-0.97, per 100 patients rostered). Additional associations were identified for series completion.

conclusionsFamily physician delivery achieved moderately high coverage in the program's first three years. This assessment demonstrates the usefulness of EMR data for evaluating vaccine coverage. Important insights into factors associated with initiation or completion (i.e. high continuity of care, smaller roster sizes, rural practice location) suggest areas for research and potential program supports.

Indexed as

Immunization ProgramsChild, PreschoolCohort StudiesConfidence IntervalsElectronic Health RecordsFamily PracticeFemaleHealth Information InteroperabilityHumansInfantInfant, NewbornInformation Storage and RetrievalLogistic ModelsMaleMultivariate AnalysisOdds RatioRotavirus Vaccines

Identifiers

PMID29444167
PMCPMC5812625
OpenAlexW2792927636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.